601567 三星医疗
2025/06 - 中期
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(59,256)1,836,1841,901,3071,222,585198,943
投资活动产生之现金流量净额233,919(2,026,739)(562,738)(170,810)771,901
筹资活动产生之现金流量净额(1,856,656)(629,214)1,174,529(1,222,689)(364,205)
汇率变动对现金及现金等价物的影响(19,450)(82,220)(1,168)(2,009)(21,694)
现金及现金等价物净增加/(减少)(1,701,443)(901,989)2,511,930(172,923)584,945
期初现金及现金等价物余额4,140,6975,042,6862,530,7562,703,6792,118,734
期末现金及现金等价物余额2,439,2544,140,6975,042,6862,530,7562,703,679